SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-051295
Filing Date
2020-11-05
Accepted
2020-11-05 16:05:55
Documents
13
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20201105.htm   iXBRL 8-K 45826
2 EX-99.1 fgen-ex991_6.htm EX-99.1 340982
  Complete submission text file 0001564590-20-051295.txt   528705

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fgen-20201105.xsd EX-101.SCH 5776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20201105_lab.xml EX-101.LAB 18732
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20201105_pre.xml EX-101.PRE 11173
6 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20201105_htm.xml XML 3406
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 201290416
SIC: 2834 Pharmaceutical Preparations